FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966517895> ?p ?o ?g. }

• W1966517895 endingPage "2339" @default.
• W1966517895 startingPage "2330" @default.
• W1966517895 abstract "Limited information exists describing the results of transcatheter aortic valve (TAV) replacement in patients with bicuspid aortic valve (BAV) disease (TAV-in-BAV). This study sought to evaluate clinical outcomes of a large cohort of patients undergoing TAV-in-BAV. We retrospectively collected baseline characteristics, procedural data, and clinical follow-up findings from 12 centers in Europe and Canada that had performed TAV-in-BAV. A total of 139 patients underwent TAV-in-BAV with the balloon-expandable transcatheter heart valve (THV) (n = 48) or self-expandable THV (n = 91) systems. Patient mean age and Society of Thoracic Surgeons predicted risk of mortality scores were 78.0 ± 8.9 years and 4.9 ± 3.4%, respectively. BAV stenosis occurred in 65.5%, regurgitation in 0.7%, and mixed disease in 33.8% of patients. Incidence of type 0 BAV was 26.7%; type 1 BAV was 68.3%; and type 2 BAV was 5.0%. Multislice computed tomography (MSCT)-based TAV sizing was used in 63.5% of patients (77.1% balloon-expandable THV vs. 56.0% self-expandable THV, p = 0.02). Procedural mortality was 3.6%, with TAV embolization in 2.2% and conversion to surgery in 2.2%. The mean aortic gradient decreased from 48.7 ± 16.5 mm Hg to 11.4 ± 9.9 mm Hg (p < 0.0001). Post-implantation aortic regurgitation (AR) grade ≥2 occurred in 28.4% (19.6% balloon-expandable THV vs. 32.2% self-expandable THV, p = 0.11) but was prevalent in only 17.4% when MSCT-based TAV sizing was performed (16.7% balloon-expandable THV vs. 17.6% self-expandable THV, p = 0.99). MSCT sizing was associated with reduced AR on multivariate analysis (odds ratio [OR]: 0.19, 95% confidence intervals [CI]: 0.08 to 0.45; p < 0.0001). Thirty-day device safety, success, and efficacy were noted in 79.1%, 89.9%, and 84.9% of patients, respectively. One-year mortality was 17.5%. Major vascular complications were associated with increased 1-year mortality (OR: 5.66, 95% CI: 1.21 to 26.43; p = 0.03). TAV-in-BAV is feasible with encouraging short- and intermediate-term clinical outcomes. Importantly, a high incidence of post-implantation AR is observed, which appears to be mitigated by MSCT-based TAV sizing. Given the suboptimal echocardiographic results, further study is required to evaluate long-term efficacy." @default.
• W1966517895 created "2016-06-24" @default.
• W1966517895 creator A5003293616 @default.
• W1966517895 creator A5004549218 @default.
• W1966517895 creator A5008177500 @default.
• W1966517895 creator A5009829953 @default.
• W1966517895 creator A5016448855 @default.
• W1966517895 creator A5018163669 @default.
• W1966517895 creator A5018800965 @default.
• W1966517895 creator A5022965816 @default.
• W1966517895 creator A5026998439 @default.
• W1966517895 creator A5030693549 @default.
• W1966517895 creator A5031805060 @default.
• W1966517895 creator A5033599517 @default.
• W1966517895 creator A5036812135 @default.
• W1966517895 creator A5037773443 @default.
• W1966517895 creator A5039252368 @default.
• W1966517895 creator A5039789130 @default.
• W1966517895 creator A5040339119 @default.
• W1966517895 creator A5041250456 @default.
• W1966517895 creator A5041706037 @default.
• W1966517895 creator A5043998687 @default.
• W1966517895 creator A5049024917 @default.
• W1966517895 creator A5053194091 @default.
• W1966517895 creator A5057508716 @default.
• W1966517895 creator A5061220352 @default.
• W1966517895 creator A5067174039 @default.
• W1966517895 creator A5075664480 @default.
• W1966517895 date "2014-12-01" @default.
• W1966517895 modified "2023-10-18" @default.
• W1966517895 title "Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Disease" @default.
• W1966517895 cites W1512029943 @default.
• W1966517895 cites W19802686 @default.
• W1966517895 cites W1993630998 @default.
• W1966517895 cites W1998297154 @default.
• W1966517895 cites W2000967076 @default.
• W1966517895 cites W2007071097 @default.
• W1966517895 cites W2009392121 @default.
• W1966517895 cites W2020292999 @default.
• W1966517895 cites W2023833069 @default.
• W1966517895 cites W2033687467 @default.
• W1966517895 cites W2035479977 @default.
• W1966517895 cites W2038230088 @default.
• W1966517895 cites W2041617439 @default.
• W1966517895 cites W2045050766 @default.
• W1966517895 cites W2057170594 @default.
• W1966517895 cites W2057797574 @default.
• W1966517895 cites W2066819932 @default.
• W1966517895 cites W2074979486 @default.
• W1966517895 cites W2087967794 @default.
• W1966517895 cites W2090320813 @default.
• W1966517895 cites W2091363951 @default.
• W1966517895 cites W2091671279 @default.
• W1966517895 cites W2102129596 @default.
• W1966517895 cites W2103596729 @default.
• W1966517895 cites W2107912271 @default.
• W1966517895 cites W2108007523 @default.
• W1966517895 cites W2110226194 @default.
• W1966517895 cites W2121800766 @default.
• W1966517895 cites W2121967184 @default.
• W1966517895 cites W2124185664 @default.
• W1966517895 cites W2125431183 @default.
• W1966517895 cites W2134855279 @default.
• W1966517895 cites W2140033602 @default.
• W1966517895 cites W2149609916 @default.
• W1966517895 cites W2165258820 @default.
• W1966517895 cites W2166457346 @default.
• W1966517895 cites W2166973706 @default.
• W1966517895 cites W2236707336 @default.
• W1966517895 cites W2547415278 @default.
• W1966517895 cites W38964970 @default.
• W1966517895 cites W4205993996 @default.
• W1966517895 cites W4237799954 @default.
• W1966517895 doi "https://doi.org/10.1016/j.jacc.2014.09.039" @default.
• W1966517895 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25465419" @default.
• W1966517895 hasPublicationYear "2014" @default.
• W1966517895 type Work @default.
• W1966517895 sameAs 1966517895 @default.
• W1966517895 citedByCount "261" @default.
• W1966517895 countsByYear W19665178952014 @default.
• W1966517895 countsByYear W19665178952015 @default.
• W1966517895 countsByYear W19665178952016 @default.
• W1966517895 countsByYear W19665178952017 @default.
• W1966517895 countsByYear W19665178952018 @default.
• W1966517895 countsByYear W19665178952019 @default.
• W1966517895 countsByYear W19665178952020 @default.
• W1966517895 countsByYear W19665178952021 @default.
• W1966517895 countsByYear W19665178952022 @default.
• W1966517895 countsByYear W19665178952023 @default.
• W1966517895 crossrefType "journal-article" @default.
• W1966517895 hasAuthorship W1966517895A5003293616 @default.
• W1966517895 hasAuthorship W1966517895A5004549218 @default.
• W1966517895 hasAuthorship W1966517895A5008177500 @default.
• W1966517895 hasAuthorship W1966517895A5009829953 @default.
• W1966517895 hasAuthorship W1966517895A5016448855 @default.
• W1966517895 hasAuthorship W1966517895A5018163669 @default.
• W1966517895 hasAuthorship W1966517895A5018800965 @default.
• W1966517895 hasAuthorship W1966517895A5022965816 @default.

• next